Even as the Philippines directed its collective attention toward the pandemic, a quieter epidemic continued its toll: stroke, the country's third leading cause of death, claimed nearly 100,000 Filipino lives in 2020 alone. In September 2021, Menarini Asia-Pac convened medical experts and a stroke survivor to illuminate how atrial fibrillation silently manufactures the blood clots that travel to the brain—and how that journey, so often fatal, is preventable. The campaign is a reminder that the oldest threats to human life do not pause for newer ones, and that prevention is less a medical miracl
Blood clots pose hidden threat as NCDs deprioritized during pandemic
Cobertura Relacionada
Dozens of UK homebuyers report serious defects in new-build properties including mould, structural issues, and damp. Com…
The Guardian · Sep 04 New Zealand becomes second nation to approve MDMA for severe PTSD treatmentNew Zealand's Medsafe approved two psychiatrists to prescribe pharmaceutical-grade MDMA for severe PTSD, making it only …
Insurance Business · Sep 04 Intact Insurance Defeats Chronic Pain Claim Under Ontario's Minor Injury CapA Licence Appeal Tribunal rejected a claimant's attempt to exceed Ontario's $3,500 minor injury cap following a 2023 car…
News-Medical · Sep 04 Study identifies how prednisone impairs bone health in children with muscular dystrophyResearch identifies blood proteins explaining how prednisone, while treating Duchenne muscular dystrophy, impairs childh…
Impacto Geopolítico
This article is a health awareness campaign, not geopolitical news. It lacks international relations, power dynamics, or cross-border implications relevant to geopolitical analysis.
Viés e Enquadramento
Article promotes pharmaceutical company's awareness campaign on blood clots with minimal critical perspective on corporate messaging or potential conflicts of interest.
Sponsored content framing disguised as health journalism; uses public health crisis (COVID deprioritization of NCDs) as narrative hook to legitimize corporate campaign without disclosing commercial interests or examining industry motivations.
Lente Econômica
Pharmaceutical awareness campaign highlights thrombosis risks amid NCD deprioritization during pandemic, signaling potential market opportunity for anticoagulant medications and preventive healthcare services in Philippines.
Increased medication adherence and preventive care awareness may reduce out-of-pocket emergency healthcare costs for Filipino households, though chronic medication expenses could rise. Stroke prevention through anticoagulant therapy represents significant long-term healthcare spending.
Government may need to rebalance healthcare priorities toward NCDs despite pandemic focus, potentially increasing pharmaceutical subsidies for anticoagulants, strengthening stroke prevention programs, and integrating thrombosis screening into primary care protocols. Insurance coverage expansion for preventive medications may be warranted.